Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore AbbVie's groundbreaking GAIA Platform in this 27-minute conference talk from AWS re:Invent 2025, where pharmaceutical leaders demonstrate how their enterprise AI-powered document creation solution is revolutionizing clinical trial processes. Discover how GAIA successfully generates clinical documents while reducing manual writing effort by up to 80% through full integration with data sources and AI-driven automation. Learn about AbbVie's transformation journey from traditional AI approaches to implementing generative AI and intelligent agents for producing high-quality, accurate, human-in-the-loop, GxP-ready outputs with single-click functionality. Gain insights into how these technological advancements are accelerating AbbVie's end-to-end clinical processes and reshaping pharmaceutical R&D workflows. Understand the practical implementation challenges, solutions, and measurable impacts of deploying enterprise AI in highly regulated pharmaceutical environments where accuracy and compliance are paramount.
